News
Blood Proteins May Predict MASLD Up to 16 Years Before Symptoms - (https://news.ddw.org/news/blood-proteins-may-predict-masld ...
A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...
15hon MSN
Liver disease is on the rise and it is very important to protect this vital organ as the world we live in is full of toxins.
A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction ...
Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic dysfunction-associated steatohepatitis and moderate or advanced liver ...
Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate Updates
Rezdiffra™ (resmetirom) net sales of $137.3 million As of March 31, 2025, more than 17,000 patients on Rezdiffra Two-year compensated MASH cirrhosis (F4c) data from MAESTRO-NAFLD-1 trial selected as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results